[1]DHIMAN RK, SARASWAT VA, SHARMA BK, et al.Minimal hepatic encephalopathy:consensus statement of a working part of the Indian National Association for Study of the Liver[J].J Gastroenterol Hepatol, 2010, 25 (6) :1029-1041.
|
[2]LI SW, XU JM, HU KF, et al.Prevalence of minimal hepatic encephalopathy and analysis of associated risk factors[J].Chin J Gastroenterol Hepatol, 2012, 21 (2) :176-179. (in Chinese) 李素文, 许建明, 胡凯风, 等.轻微肝性脑病患病情况调查及相关危险因素分析[J].胃肠病学和肝病学杂志, 2012, 21 (2) :176-179.
|
[3]LIN Y, FAN YP.The neuropsychologic tests and the minimal hepatic encephalopathy investigations in liver cirrhotic patients[J].Chin J Hepatol, 2011, 19 (1) :65-66. (in Chinese) 林言, 范燕萍.肝硬化患者的神经心理测验及轻微肝性脑病调查[J].中华肝脏病杂志, 2011, 19 (1) :65-66.
|
[4]ZHAN T, STREMMEL W.The diagnosis and treatment of minimal hepatic encephalopathy[J].Dtsch Arztebl Int, 2012, 109 (10) :180-187.
|
[5]MONTGOMERY JY, BAJAJ JS.Advances in the evaluation and management of minimal hepatic encephalopathy[J].Curr Gastroenterol Rep, 2011, 13 (1) :26-33.
|
[6]MULLWN KD, PRAKASH RK.Management of covert hepatic encephalopathy[J].Clin Liver Dis, 2012, 16 (1) :91-93.
|
[7]BAJAJ JS, SAEIAN K, SCHUBERT CM, et al.Minimal hepatic encephalopathy is associated with motor vehicle crashes:the reality beyond the driving test[J].Hepatology, 2009, 50 (4) :1175-1183.
|
[8]BAJAJ JS, HEUMAN DM, WADE JB, et al.Rifaximin improves driving simulator performance in a randomizes trial of patients with minimal hepatic encephalopathy[J].Gastroenterology, 2011, 140 (2) :478-487.
|
[9]PRAKASH R, MULLEN KD.Mechanisms, diagnosis and management of hepatic encephalopathy[J].Nat Rev Gastroenterol Hepatol, 2010, 7 (9) :515-525.
|
[10]WEN J, LIU Q, SONG J, et al.Lactulose is highly potential in prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding:results of a controlled randomized trial[J].Digestion, 2013, 87 (2) :132-138.
|
[11]MITTAL VV, SHARMA BC, SHARMA P, et al.A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy[J].Eur J Gastroenterol Hepatol, 2011, 23 (8) :725-732.
|
[12]BAJAJ JS, HEUMAN DM, SANYAL AJ, et al.Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy[J].PLoS One, 2013, 8 (4) :e60042.
|
[13]SIDHU SS, GOYAL O, MISHRA BP, et al.Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial) [J].Am J Gastroenterol, 2011, 106 (2) :307-316.
|
[14]SAJI S, KUMAR S, THOMAS V.A randomized double blind placebo controlled trial of probiotics in minimal hepatic encephalopathy[J].Trop Gastroenterol, 2011, 32 (2) :128-132.
|
[15]SHARMA P, SHARMA BC, PURI V.An open-label randomized controlled trial of lactuloseand probiotics in the treatment of minimal hepatic encephalopathy[J].Eur J Gastroenterol Hepatol, 2008, 20 (6) :506-511.
|
[16]SHUKLA S, SHUKLA A, MEHBOOB S, et al.Meta-analysis:the effects of gut flora modulationusing prebiotics, probiotics and synbiotics on minimal hepatic encephalopathy[J].Aliment Pharmacol Ther, 2011, 33 (6) :662-671.
|
[17]LES I, DOVAL E, GARCIA-MARTINEZ R, et al.Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy:a randomized study[J].Am J Gastroenterol, 2011, 106 (6) :1081-1088.
|
[18]BAI M, YANG Z, QI X, et al.l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis:a meta-analysis of randomized controlled trials[J].J Gastroenterol Hepatol, 2013, 28 (5) :783-792.
|
[19]KATO A, TANAKA H, KAWAGUCHI T, et al.Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis:A preliminary, prospective, open-label study[J].Hepatol Res, 2013, 43 (5) :452-458.
|
[20]VAISMAN N, KATZMAN H, CARMIEL-HAGGAI M, et al.Breakfast improves cognitive function in cirrhotic patients with cognitive impairment[J].Am J Clin Nutr, 2010, 92 (1) :137-140.
|